Varenne Capital Partners’s CME Group CME Stock Holding History

Varenne Capital Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-86,050	Closed	-$23.7M	–	25
2025 Q2	$23.7M	Buy	+86,050	New	+$23.4M	4.11%	11

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Varenne Capital Partners's CME Position: Q3 2025 in Review

Varenne Capital Partners sold out of CME Group (CME) in Q3 2025, closing a stake of 86,050 shares — an estimated $23.7M sold.

Varenne Capital Partners first reported a position in CME in Q2 2025 and held it in 1 quarter. The position peaked at $23.7M in Q2 2025. 1,651 funds tracked by Wall St. Rank hold CME as of Q3 2025.

Varenne Capital Partners reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
Varenne Capital Partners sold 86,050 CME Group shares in Q3 2025, an estimated $23.7M.
Varenne Capital Partners first reported a position in CME Group in Q2 2025 and held it in 1 quarter.
Varenne Capital Partners's CME Group position peaked at $23.7M in Q2 2025.
1,651 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Varenne Capital Partners's 13F filing for Q3 2025, filed 12 Nov 2025.